Graph Therapeutics brings total funding to over $10M to advance precision immunology

Graph Therapeutics is a biotech company developing precision medicines for inflammatory and immune-mediated diseases using AI-powered analysis of live patient cells, multi-omics data, and functional biology.

View Post on Scour ↗

More from tech.eu on Scour.